Becker’s Healthcare Podcast podcast

Using AI to Power Custom Treatments for Rare Diseases with Steven Ringel

0:00
10:18
Manda indietro di 15 secondi
Manda avanti di 15 secondi

In this episode, Steven Ringel, CEO of the Kazuna Foundation and Nome Therapeutics, joins the podcast to discuss how his team is using artificial intelligence to make personalized medicine accessible for rare disease patients. He shares emerging trends in AI and healthcare, the growing potential of individualized therapies, and his advice for passionate leaders driving innovation in the field.

Altri episodi di "Becker’s Healthcare Podcast"